Publications by authors named "Katsumasa Kudo"
[Efficacy of neoadjuvant chemotherapy for resectable pancreatic carcinoma].
Gan To Kagaku Ryoho
November 2013
Surgery followed by adjuvant chemotherapy is standard care for resectable pancreatic carcinoma. The maximum estimated 2-year survival rate associated with this strategy is nearly 50%. The use of neoadjuvant therapy for pancreatic cancer remains controversial, and its efficacy has not been elucidated.
View Article and Find Full Text PDF[Q & A. Case of aspiration pneumonia resulting in duodenal obstruction].
Nihon Shokakibyo Gakkai Zasshi
August 2012